ResMed | RMD - Ebitda

Aktienkurs
227.97
Täglich Wechseln
1.98 0.88%
Monatlich
-9.40%
Jährlich
2.27%
Q1 Prognose
219.21




Ebitda Veränderung Datum
Ansell USD 185.8M 7M 2025-12
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Baxter International USD 426M 36M 2025-09
Cochlear AUD 306.4M 13.5M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
CSL USD 3.13B 1.17B 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Fisher Paykel Healthcare NZD 364M 78.5M 2025-06
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Idexx Laboratories USD 391.47M 17.97M 2025-09
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 919.7M 21M 2025-09
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Philips EUR 738M 9M 2025-09
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Sigma Healthcare AUD 19.96M 5.15M 2024-07
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Steris USD 389.7M 22.5M 2025-09
Teleflex USD -328.81M 536.43M 2025-09
Thermo Fisher Scientific USD 3.17B 335M 2025-12